CONVENTIONAL VS CONTROLLED-RELEASE CARBAMAZEPINE - A MULTICENTER, DOUBLE-BLIND, CROSS-OVER STUDY

被引：0
|
作者：
CANGER, R
ALTAMURA, AC
BELVEDERE, O
MONACO, F
MONZA, GC
MUSCAS, GC
MUTANI, R
PANETTA, B
PISANI, F
ZACCARA, G
ZAGNONI, PG
机构：
[1] UNIV SASSARI, DEPT NEUROL, I-07100 SASSARI, ITALY
[2] UNIV FLORENCE, DEPT NEUROL, I-50121 FLORENCE, ITALY
[3] UNIV TURIN, DEPT NEUROL, NOVARA, ITALY
[4] UNIV MESSINA, DEPT NEUROL, I-98100 MESSINA, ITALY
[5] SANTA CROCE HOSP, DEPT NEUROL, CUNEO, ITALY
[6] UNIV MILAN, DEPT PSYCHIAT, I-20122 MILAN, ITALY
来源：
ACTA NEUROLOGICA SCANDINAVICA | 1990年 / 82卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：9 / 13
页数：5
相关论文
共 50 条
  • [21] Dapsone in Behcet's disease: A double-blind, placebo-controlled, cross-over study
    Sharquie, KE
    Najim, RA
    Abu-Raghif, AR
    JOURNAL OF DERMATOLOGY, 2002, 29 (05): : 267 - 279
  • [22] Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study
    Drueke, Barbara
    Baetz, Julia
    Boecker, Maren
    Moeller, Olaf
    Hiemke, Christoph
    Gruender, Gerd
    Gauggel, Siegfried
    PSYCHOPHARMACOLOGY, 2009, 207 (02) : 213 - 223
  • [23] Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study
    Barbara Drueke
    Julia Baetz
    Maren Boecker
    Olaf Moeller
    Christoph Hiemke
    Gerd Gründer
    Siegfried Gauggel
    Psychopharmacology, 2009, 207 : 213 - 223
  • [24] TREATMENT OF OSTEOARTHRITIS WITH A HERBOMINERAL FORMULATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY
    KULKARNI, RR
    PATKI, PS
    JOG, VP
    GANDAGE, SG
    PATWARDHAN, B
    JOURNAL OF ETHNOPHARMACOLOGY, 1991, 33 (1-2) : 91 - 95
  • [25] Levodopa for chronic neck pain: A cross-over double-blind, placebo-controlled study
    Marziniak, M
    Guralnik, V
    Dillmann, U
    Becker, G
    MOVEMENT DISORDERS, 2004, 19 : S393 - S394
  • [26] Baclofen treatment for rumination syndrome: a double-blind, placebo-controlled, cross-over study
    Pauwels, A.
    Broers, C.
    Van Houtte, B.
    Rommel, N.
    Vanuytsel, T.
    Tack, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 19 - 19
  • [27] Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study
    G. S. Ungvari
    Helen F. K. Chiu
    Lok Yee Chow
    Benjamin S. T. Lau
    Wai Kwong Tang
    Psychopharmacology, 1999, 142 : 393 - 398
  • [28] A COMPARISON OF THE EFFICACY AND TOLERABILITY OF CONTROLLED-RELEASE CARBAMAZEPINE WITH CONVENTIONAL CARBAMAZEPINE
    DHALLA, Z
    BRUNI, J
    SUTTON, J
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1991, 18 (01) : 66 - 68
  • [29] AFRODEX IN TREATMENT OF MALE IMPOTENCE - A DOUBLE-BLIND CROSS-OVER STUDY
    MILLER, WW
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1968, 10 (07): : 354 - &
  • [30] Nicotine and behavioral markers of risk for schizophrenia:: A double-blind, placebo-controlled, cross-over study
    Dépatie, L
    O'Driscoll, GA
    Holahan, ALV
    Atkinson, V
    Thavundayil, JX
    Kin, NNY
    Lal, S
    NEUROPSYCHOPHARMACOLOGY, 2002, 27 (06) : 1056 - 1070
12345